Table 2.
Factor | Control | Cisplatin | Cisplatin+TMZ | Cisplatin+CoQ10 | Cisplatin+TMZ+CoQ10 |
---|---|---|---|---|---|
Nrf2/Lamin A | 1±0.17 | 0.41±0.09*** | 0.6±0.07# | 0.63±0.1# | 0.87±0.06###$ |
Cyto-c/GAPDH | 1±0.29 | 17.55±2.94*** | 10.76±1.35## | 9.65±1.78## | 6.71±1.02###$ |
Nrf2/GAPDH | 1±0.15 | 1.23±0.12 | 1±0.16 | 1.06±0.07 | 0.91±0.19 |
Cyto-c/COX IV | 1±0.22 | 0.24±0.07*** | 0.47±0.05# | 0.56±0.11## | 0.65±0.12###$ |
P<0.001 as compared with control;
P<0.05,
P<0.01, and
P<0.001 as compared with cisplatin-treated cells;
P<0.05 as compared with TMZ or CoQ10-pretreated cells.
TMZ - trimetazidine; CoQ10 - coenzyme Q10